Katelyn A. Mazzochi MD , Sheraya De Silva BSc(Hon) , Nicholas L.M. Chan MD , Erin McGann MPhysio , Tayla L. Robertson MPhysioPrac , Tahnee R. Hellings MPhysioPrac , Carol L. Hodgson PhD , Alisa M. Higgins PhD
{"title":"Long-Term Outcomes of Patients With COVID-19 Who Are Critically Ill","authors":"Katelyn A. Mazzochi MD , Sheraya De Silva BSc(Hon) , Nicholas L.M. Chan MD , Erin McGann MPhysio , Tayla L. Robertson MPhysioPrac , Tahnee R. Hellings MPhysioPrac , Carol L. Hodgson PhD , Alisa M. Higgins PhD","doi":"10.1016/j.chstcc.2024.100108","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Survivors of critical illness are susceptible to long-term functional impairments after admission to an ICU. During the COVID-19 pandemic, the number of patients admitted to an ICU with SARS-CoV-2 infection surged. The long-term consequences of critical illness resulting from COVID-19 illness remain unclear.</div></div><div><h3>Research Question</h3><div>What are the long-term outcomes of adult patients admitted to an ICU for COVID-19?</div></div><div><h3>Study Design and Methods</h3><div>We searched Ovid MEDLINE and EMBASE using subject heading and free-text terms related to long-term outcomes of critically ill patients with COVID-19. We included all articles that reported original data on outcomes from 90 days onward for adult patients admitted to an ICU for COVID-19. Data extracted included study details, patient characteristics, outcomes reported, measurement tools used, and timing of assessment.</div></div><div><h3>Results</h3><div>A total of 14,882 studies were screened, from which 134 studies fulfilled the selection criteria. Follow-up time points ranged from 90 days to 2 years after critical illness. Mortality after hospitalization was the most reported outcome (n = 60), with the general ICU cohort having an aggregate mortality rate of 35.5% (95% CI, 34.7%-36.2%) at 90 days and 31.6% (95% CI, 30.9%-32.4%) at 6 months. A plethora of other outcomes were assessed, including psychologic function and mental health (n = 49), persistent symptoms (n = 47), quality of life (n = 47), physical function (n = 33), and cognitive function (n = 31). For each outcome, different measurement tools were used, making data synthesis across studies difficult.</div></div><div><h3>Interpretation</h3><div>Important evidence gaps remain regarding the long-term health outcomes and health care needs for survivors of critical COVID-19 illness. This review found that mortality was the most reported long-term outcome. Significant heterogeneity was evident across studies in terms of outcomes assessed, measurement instruments used, and the duration of follow-up. Future research requires increased consistency in outcomes assessed and measurement tools to inform clinical practice.</div></div>","PeriodicalId":93934,"journal":{"name":"CHEST critical care","volume":"3 1","pages":"Article 100108"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CHEST critical care","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949788424000625","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Survivors of critical illness are susceptible to long-term functional impairments after admission to an ICU. During the COVID-19 pandemic, the number of patients admitted to an ICU with SARS-CoV-2 infection surged. The long-term consequences of critical illness resulting from COVID-19 illness remain unclear.
Research Question
What are the long-term outcomes of adult patients admitted to an ICU for COVID-19?
Study Design and Methods
We searched Ovid MEDLINE and EMBASE using subject heading and free-text terms related to long-term outcomes of critically ill patients with COVID-19. We included all articles that reported original data on outcomes from 90 days onward for adult patients admitted to an ICU for COVID-19. Data extracted included study details, patient characteristics, outcomes reported, measurement tools used, and timing of assessment.
Results
A total of 14,882 studies were screened, from which 134 studies fulfilled the selection criteria. Follow-up time points ranged from 90 days to 2 years after critical illness. Mortality after hospitalization was the most reported outcome (n = 60), with the general ICU cohort having an aggregate mortality rate of 35.5% (95% CI, 34.7%-36.2%) at 90 days and 31.6% (95% CI, 30.9%-32.4%) at 6 months. A plethora of other outcomes were assessed, including psychologic function and mental health (n = 49), persistent symptoms (n = 47), quality of life (n = 47), physical function (n = 33), and cognitive function (n = 31). For each outcome, different measurement tools were used, making data synthesis across studies difficult.
Interpretation
Important evidence gaps remain regarding the long-term health outcomes and health care needs for survivors of critical COVID-19 illness. This review found that mortality was the most reported long-term outcome. Significant heterogeneity was evident across studies in terms of outcomes assessed, measurement instruments used, and the duration of follow-up. Future research requires increased consistency in outcomes assessed and measurement tools to inform clinical practice.